138 related articles for article (PubMed ID: 16313300)
1. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
[TBL] [Abstract][Full Text] [Related]
2. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
3. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma.
Howell WM; Bateman AC; Turner SJ; Collins A; Theaker JM
Genes Immun; 2002 Jun; 3(4):229-32. PubMed ID: 12058259
[TBL] [Abstract][Full Text] [Related]
4. High risk of cutaneous melanoma amongst carriers of the intercellular adhesion molecule-1 R241 allele.
Vinceti M; Pellacani G; Casali B; Malagoli C; Nicoli D; Farnetti E; Bassissi S; Bergomi M; Seidenari S
Melanoma Res; 2006 Feb; 16(1):93-6. PubMed ID: 16432463
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
Smith KC; Bateman AC; Fussell HM; Howell WM
Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura.
Amoli MM; Mattey DL; Calviño MC; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2001 May; 28(5):1014-8. PubMed ID: 11361181
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis.
Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2001 Jul; 28(7):1600-4. PubMed ID: 11469468
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
Li C; Hu Z; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer; 2007 Apr; 109(8):1570-8. PubMed ID: 17328085
[TBL] [Abstract][Full Text] [Related]
12. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
13. Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis.
Howell WM; Pead PJ; Shek FW; Rose-Zerilli MJ; Armstrong T; Johnson CD; Fine DR; Iredale JP; Bateman AC
J Clin Pathol; 2005 Jun; 58(6):595-9. PubMed ID: 15917409
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
Howell WM; Turner SJ; Theaker JM; Bateman AC
Eur J Immunogenet; 2003 Dec; 30(6):409-14. PubMed ID: 14675394
[TBL] [Abstract][Full Text] [Related]
15. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
16. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
McCarron SL; Bateman AC; Theaker JM; Howell WM
Int J Cancer; 2003 Nov; 107(4):673-5. PubMed ID: 14520709
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica.
Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2002 Mar; 29(3):502-4. PubMed ID: 11911111
[TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer.
Arandi N; Talei A; Erfani N; Ghaderi A
Cancer Genet Cytogenet; 2008 May; 183(1):9-13. PubMed ID: 18474291
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease.
Boiardi L; Salvarani C; Casali B; Olivieri I; Ciancio G; Cantini F; Salvi F; Malatesta R; Govoni M; Trotta F; Filippini D; Paolazzi G; Nicoli D; Farnetti E; Macchioni L
J Rheumatol; 2001 Jun; 28(6):1283-7. PubMed ID: 11409120
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers.
Zhang XQ; Hong XJ; Bai XJ
J Viral Hepat; 2008 Mar; 15(3):173-8. PubMed ID: 18233990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
